Literature DB >> 35121906

LAG-3 and PD-1 blockade raises the bar for melanoma.

Caroline Robert1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 35121906     DOI： 10.1038/s43018-021-00276-8

Source DB:  PubMed          Journal:  Nat Cancer        ISSN： 2662-1347


× No keyword cloud information.
  1 in total

1.  Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Authors:  James Larkin; Vanna Chiarion-Sileni; Rene Gonzalez; Jean-Jacques Grob; Piotr Rutkowski; Christopher D Lao; C Lance Cowey; Dirk Schadendorf; John Wagstaff; Reinhard Dummer; Pier F Ferrucci; Michael Smylie; David Hogg; Andrew Hill; Ivan Márquez-Rodas; John Haanen; Massimo Guidoboni; Michele Maio; Patrick Schöffski; Matteo S Carlino; Céleste Lebbé; Grant McArthur; Paolo A Ascierto; Gregory A Daniels; Georgina V Long; Lars Bastholt; Jasmine I Rizzo; Agnes Balogh; Andriy Moshyk; F Stephen Hodi; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2019-09-28       Impact factor: 91.245
  1 in total
  5 in total

1.  Differential Effects on the Translation of Immune-Related Alternatively Polyadenylated mRNAs in Melanoma and T Cells by eIF4A Inhibition.

Authors:  Biswendu Biswas; Ramdane Guemiri; Mandy Cadix; Céline M Labbé; Alina Chakraborty; Martin Dutertre; Caroline Robert; Stéphan Vagner
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639

2.  An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy.

Authors:  Sarah C Cowles; Allison Sheen; Luciano Santollani; Emi A Lutz; Brianna M Lax; Joseph R Palmeri; Gordon J Freeman; K Dane Wittrup
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

Review 3.  Recent advances in nano-drug delivery systems for synergistic antitumor immunotherapy.

Authors:  Bonan Zhao; Xiang Li; Ying Kong; Wenbo Wang; Tingting Wen; Yanru Zhang; Zhiyong Deng; Yafang Chen; Xian Zheng
Journal:  Front Bioeng Biotechnol       Date:  2022-09-08

Review 4.  Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.

Authors:  Dong-Rui Wang; Xian-Lin Wu; Ying-Li Sun
Journal:  Signal Transduct Target Ther       Date:  2022-09-19

Review 5.  Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment.

Authors:  Bayley R McRitchie; Billur Akkaya
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.